Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the target of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 46,964 shares, a growth of 2,398.1% from the June 15th total of 1,880 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 83,081 shares, the short-interest ratio is presently 0.6 days.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. Barclays reaffirmed an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. BMO Capital Markets assumed coverage on shares of Straumann in a report on Wednesday. They issued an “outperform” rating on the stock. Finally, Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

View Our Latest Report on Straumann

Straumann Trading Up 1.4%

OTCMKTS:SAUHY traded up $0.18 on Friday, hitting $13.03. The stock had a trading volume of 78,950 shares, compared to its average volume of 37,098. Straumann has a 1 year low of $9.44 and a 1 year high of $14.11. The firm’s fifty day simple moving average is $11.97 and its two-hundred day simple moving average is $11.65.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Featured Articles

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.